The Coopervision guidance cut is the second reduction in two quarters, signaling structural weakness in the core contact lens business. Traders should watch for further downward revisions, potential analyst downgrades, and developments in the securities investigation. The EPS beat is irrelevant given the revenue miss and guidance collapse — avoid the dip until visibility on Coopervision's channel inventory normalization improves.
Price Chart
Executive Summary
Cooper Companies (COO) fell ~15% after reporting Q3 2026 revenue ~$30M below consensus and slashing Coopervision's fiscal 2026 organic growth guidance from 4.5-5.5% to just 1-2%, marking the second cut in two quarters. The revenue miss and guidance reduction triggered a Levi & Korsinsky investigation into potentially misleading statements about Coopervision's growth outlook and channel inventory conditions. This is a clear bearish event driven by deteriorating fundamentals in the core contact lens business, with the investigation adding legal overhang.
Key Financial Metrics
Key Facts
- COO reported Q3 2026 EPS of $1.15, beating consensus of $1.07 by 7.5%
- Revenue missed consensus by ~$30M, landing ~$1.04B vs $1.07B estimate
- Coopervision fiscal 2026 organic growth guidance slashed to 1-2% from 4.5-5.5%
- Coopervision Q4 organic growth guided to -2% to 0%
- Stock fell ~15% on the news
- Levi & Korsinsky launched an investigation into potentially misleading statements about Coopervision growth and channel inventory
Financial Impact
Revenue miss of ~$30M vs consensus; Coopervision growth guidance cut from 4.5-5.5% to 1-2%; stock declined ~15%
Risk Factors
- Further guidance cuts if U.S. channel inventory reductions persist
- Securities class action litigation costs and management distraction
- Potential analyst downgrades and earnings estimate revisions
- Loss of investor confidence in Coopervision's growth trajectory
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-prn-302876667 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 16d ago | Insider Cluster | $54.61 $56.07 | ▲ +2.67% | ▲ +0.11% | $57.28 (+4.89%) |
Sep 14, 2026 17d ago | Press Release | $54.22 $54.12 | ▼ −0.18% | ▼ −0.29% | $57.28 (+5.64%) |
Sep 11, 2026 20d ago | Press Release | $54.22 $54.12 | ▲ +0.18% | ▲ +0.29% | $57.28 (−5.64%) |
Sep 9, 2026 22d ago | Press Release | $54.17 $53.78 | ▼ −0.73% | ▼ −0.23% | $57.28 (+5.74%) |
Jun 4, 2026 17w ago | 8-K | $67.34 $67.88 | ▲ +0.80% | ▲ +0.23% | $57.28 (−14.94%) |
Jun 4, 2026 17w ago | Press Release | $67.34 $67.88 | ▲ +0.80% | ▲ +0.23% | $57.28 (−14.94%) |
Mar 5, 2026 30w ago | 8-K | $76.36 $69.80 | ▼ −8.59% | ▼ −7.06% | $57.28 (−24.99%) |
Mar 5, 2026 30w ago | Press Release | $76.36 $69.80 | ▼ −8.59% | ▼ −7.06% | $57.28 (−24.99%) |
Feb 24, 2026 31w ago | DEFA14A | $83.38 $81.82 | ▼ −1.87% | ▼ −0.77% | $57.28 (−31.31%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access